Patients voice frustration as drug prices skyrocket

The escalating financing expenses that pharmaceutical producers have been grappling with are significantly impacting public health, writes ARINZE NWAFOR Financing costs of pharmaceutical manufacturing companies listed on the Nigerian Stock Exchange increased by 76.85 per cent from N628.84m in the first quarter of 2023 to N1.11bn in the same quarter in 2024, because of challenges

Read More Read More